[go: up one dir, main page]

CY1107537T1 - Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος - Google Patents

Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος

Info

Publication number
CY1107537T1
CY1107537T1 CY20071100319T CY071100319T CY1107537T1 CY 1107537 T1 CY1107537 T1 CY 1107537T1 CY 20071100319 T CY20071100319 T CY 20071100319T CY 071100319 T CY071100319 T CY 071100319T CY 1107537 T1 CY1107537 T1 CY 1107537T1
Authority
CY
Cyprus
Prior art keywords
antibody
analysis
antigon
hcv
composite hcv
Prior art date
Application number
CY20071100319T
Other languages
English (en)
Inventor
David Y Chien
Phillip Arcangel
Laura Tandeske
Carlos George-Nasciemento
Doris Coit
Angelica Medina-Selby
Original Assignee
Novartis Vaccines And Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107537(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines And Diagnostics, Inc. filed Critical Novartis Vaccines And Diagnostics, Inc.
Publication of CY1107537T1 publication Critical patent/CY1107537T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Παράχεται ανάλυση συνδυασμού αντιγόνου HCV-πυρήνα και NS3/4a αντισώματος η οποία μπορεί να ανιχνεύσει αντιγόνα και αντισώματα του HCV υφιστάμενα εντός κάποιου δείγματος με χρήση μιας και μοναδικής στερεής μήτρας, καθώς και στερεά υποστρώματα ανοσοανάλυσης για χρήση στην ανάλυση.
CY20071100319T 2000-06-15 2007-03-07 Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος CY1107537T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21208200P 2000-06-15 2000-06-15
US28086701P 2001-04-02 2001-04-02
US28081101P 2001-04-02 2001-04-02
EP01952160A EP1354204B2 (en) 2000-06-15 2001-06-14 Hcv antigen/antibody combination assay

Publications (1)

Publication Number Publication Date
CY1107537T1 true CY1107537T1 (el) 2013-03-13

Family

ID=27395684

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20071100319T CY1107537T1 (el) 2000-06-15 2007-03-07 Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
CY20071101092T CY1106820T1 (el) 2000-06-15 2007-08-20 Ανοσοδοκιμασιες για αντι-hcv αντισωματα

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20071101092T CY1106820T1 (el) 2000-06-15 2007-08-20 Ανοσοδοκιμασιες για αντι-hcv αντισωματα

Country Status (22)

Country Link
US (5) US6630298B2 (el)
EP (2) EP1354204B2 (el)
JP (3) JP4834279B2 (el)
CN (3) CN1214244C (el)
AT (2) ATE348337T1 (el)
AU (2) AU2001272948A1 (el)
BG (1) BG66205B1 (el)
BR (2) BRPI0111682B8 (el)
CA (2) CA2413003C (el)
CY (2) CY1107537T1 (el)
CZ (1) CZ304185B6 (el)
DE (2) DE60125240T3 (el)
DK (2) DK1350105T3 (el)
ES (2) ES2288969T3 (el)
HU (1) HU228873B1 (el)
MX (2) MXPA02012401A (el)
NO (1) NO332275B1 (el)
PL (1) PL213363B1 (el)
PT (2) PT1350105E (el)
SI (1) SI1354204T2 (el)
SK (1) SK287694B6 (el)
WO (2) WO2001096875A2 (el)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1421951A3 (en) * 1993-05-12 2005-10-05 Chiron Corporation Conserved motif of hepatitis C virus E2/NS1 region
ES2288969T3 (es) * 2000-06-15 2008-02-01 Novartis Vaccines And Diagnostics, Inc. Inmunoensayos para anticuerpos anti-hcv.
US7491808B2 (en) * 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
KR20070114209A (ko) * 2000-08-17 2007-11-29 트리펩 아베 리바비린 함유 백신 및 이것의 사용 방법
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
DE10106295C1 (de) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist
AR033448A1 (es) * 2001-03-28 2003-12-17 Ortho Clinical Diagnostics Inc Prueba de combinacion antigeno-anticuerpo para hepatitis c para una deteccion temprana de la infeccion
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
CA2450710C (en) 2001-06-26 2013-11-26 Abbott Laboratories Methods for the simultaneous detection of hcv antigens and hcv antibodies
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
MXPA05002641A (es) * 2002-09-09 2005-05-05 Chiron Corp Ensayo del virus de la hepatitis c.
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
US20070003977A1 (en) 2003-08-20 2007-01-04 Amorfix Life Sciences Ltd Epitope protection assay and method for detecting protein conformations
ES2377978T3 (es) 2004-08-27 2012-04-03 Novartis Vaccines And Diagnostics, Inc. Mutantes de proteínas no estructurales de VHC y usos de los mismos
EP1845378A4 (en) * 2005-02-02 2008-09-17 Peng Cui KIT ANTIBODY DETECTION KIT AND PREPARATION METHOD THEREOF
EP1969001A2 (en) 2005-11-22 2008-09-17 Novartis Vaccines and Diagnostics, Inc. Norovirus and sapovirus antigens
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
JP5823663B2 (ja) 2006-03-03 2015-11-25 プロミス ニューロサイエンシズ インコーポレイテッド ミスフォールドｓｏｄ１媒介疾患を処置および検出するための方法および組成物
CN1908666B (zh) * 2006-08-14 2010-05-12 武汉大学 一种检测乙肝核心抗体的双夹心法酶联免疫诊断试剂盒及应用
EP2185195A2 (en) 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
WO2010112733A1 (fr) * 2009-03-30 2010-10-07 bioMérieux Support solide de détection du vhc
US20100297607A1 (en) * 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
BR112012025364A2 (pt) 2010-04-07 2015-09-22 Novartis Ag método para geração de partícula semelhante a vírus de parvovírus b19
US9612236B2 (en) * 2010-06-17 2017-04-04 Koninklijke Philips N.V. Multi epitope assay
CN103154242B (zh) 2010-07-06 2015-09-30 诺华股份有限公司 诺如病毒衍生的免疫原性组合物和方法
WO2012006500A2 (en) * 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
EP2663642B1 (en) * 2011-01-13 2017-03-01 Ortho-Clinical Diagnostics, Inc. Treponema pallidum triplet antigen
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN105228649B (zh) 2013-03-14 2019-01-18 雅培制药有限公司 Hcv抗原-抗体组合测定和方法以及用在其中的组合物
CA2906417C (en) 2013-03-14 2022-06-21 Robert Ziemann Hcv core lipid binding domain monoclonal antibodies
JP2016512241A (ja) 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
ES2832335T3 (es) 2015-03-27 2021-06-10 Ortho Clinical Diagnostics Inc Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos
US20180292408A1 (en) * 2015-04-20 2018-10-11 Qoolabs, Inc. Camelid single-domain hcv antibodies and methods of use
WO2019067415A1 (en) * 2017-09-27 2019-04-04 Bio-Rad Laboratories, Inc. DIGITAL AFFINITY LINK ASSAY
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
CN115057943B (zh) * 2022-06-22 2025-03-14 杭州水芭莎生物医药科技有限公司 一种抗菌肽融合蛋白及其制备方法和应用
CN115838420B (zh) * 2022-10-31 2023-05-05 北京科跃中楷生物技术有限公司 一种可溶性hcv重组蛋白的制备方法及其制备的抗体检测试剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU48038B (sh) * 1987-11-18 1996-10-18 Chiron Corp. Postupak za dijagnostiku ne-a, ne-v hepatitisa
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
WO1989004669A1 (en) 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
JP2730153B2 (ja) 1989-03-16 1998-03-25 日本合成ゴム株式会社 熱可塑性樹脂組成物およびその製造方法
WO1990011089A1 (en) 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
ATE211772T1 (de) * 1989-05-18 2002-01-15 Chiron Corp Nanbv-diagnostika: polynukleotide, geeignet für reihenuntersuchungen auf hepatitis c-virus
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
RO109916B1 (ro) * 1990-04-04 1995-07-28 Chiron Corp Compozitie de antigeni ai hepatitei virale c
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
PT97247B (pt) * 1991-04-03 1997-10-31 Chiron Corp Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Polypeptide des hepatitis c-virus (hiv)
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
EP0984068B1 (en) * 1993-04-27 2012-03-28 Innogenetics N.V. Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
DK0935662T3 (da) * 1996-05-24 2006-03-06 Chiron Corp Fusionsprotein med multiple epitoper
US6322965B1 (en) * 1997-02-10 2001-11-27 Advanced Life Science Institute, Inc. Chimera antigen peptide
CA2303123C (en) * 1997-09-22 2006-04-11 Chiron Corporation Method for detecting antibodies in a sample
US7316905B1 (en) * 1998-07-30 2008-01-08 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
ES2288969T3 (es) * 2000-06-15 2008-02-01 Novartis Vaccines And Diagnostics, Inc. Inmunoensayos para anticuerpos anti-hcv.

Also Published As

Publication number Publication date
BR0111682A (pt) 2004-01-06
DE60125240D1 (de) 2007-01-25
US20020192639A1 (en) 2002-12-19
US20020146685A1 (en) 2002-10-10
NO20025878D0 (no) 2002-12-06
DE60129598T2 (de) 2008-04-17
NO20025878L (no) 2003-02-12
AU2001272948A1 (en) 2001-12-24
WO2001096870A3 (en) 2003-07-31
EP1350105A2 (en) 2003-10-08
US6630298B2 (en) 2003-10-07
WO2001096875A2 (en) 2001-12-20
US7319144B2 (en) 2008-01-15
DE60125240T3 (de) 2010-10-28
CZ20024058A3 (cs) 2003-09-17
EP1354204B2 (en) 2010-04-21
PT1350105E (pt) 2007-08-13
SI1354204T1 (sl) 2007-04-30
BRPI0111731B8 (pt) 2016-08-23
ATE348337T1 (de) 2007-01-15
CA2412035A1 (en) 2001-12-20
BG107441A (bg) 2004-01-30
BRPI0111682B1 (pt) 2017-09-19
WO2001096875A9 (en) 2002-08-15
US20040265801A1 (en) 2004-12-30
CN1214244C (zh) 2005-08-10
CZ304185B6 (cs) 2013-12-11
DK1354204T4 (da) 2010-06-14
CA2413003A1 (en) 2001-12-20
PT1354204E (pt) 2007-03-30
PL365599A1 (en) 2005-01-10
WO2001096875A3 (en) 2003-08-28
DK1350105T3 (da) 2007-11-12
CN1256591C (zh) 2006-05-17
SK287694B6 (sk) 2011-06-06
JP2011125350A (ja) 2011-06-30
US7241879B2 (en) 2007-07-10
CA2413003C (en) 2013-08-13
JP2004506878A (ja) 2004-03-04
BG66205B1 (bg) 2012-01-31
HK1079796A1 (en) 2006-04-13
CY1106820T1 (el) 2012-05-23
NO332275B1 (no) 2012-08-13
CN1466682A (zh) 2004-01-07
ES2277932T3 (es) 2007-08-01
EP1354204A2 (en) 2003-10-22
JP2004510133A (ja) 2004-04-02
SK17772002A3 (sk) 2003-10-07
HU228873B1 (hu) 2013-06-28
WO2001096870A2 (en) 2001-12-20
BR0111731A (pt) 2004-02-10
DE60129598D1 (de) 2007-09-06
JP4837229B2 (ja) 2011-12-14
US20040096822A1 (en) 2004-05-20
ES2288969T3 (es) 2008-02-01
DE60125240T2 (de) 2007-07-12
MXPA02012401A (es) 2003-04-25
SI1354204T2 (sl) 2010-09-30
ATE368221T1 (de) 2007-08-15
MXPA02012424A (es) 2003-04-25
JP4834279B2 (ja) 2011-12-14
ES2277932T5 (es) 2010-06-28
HUP0500444A3 (en) 2010-03-29
US20040063092A1 (en) 2004-04-01
EP1354204B1 (en) 2006-12-13
BRPI0111682B8 (pt) 2021-07-27
EP1350105B1 (en) 2007-07-25
CA2412035C (en) 2012-04-10
BRPI0111731B1 (pt) 2016-07-05
CN1489692A (zh) 2004-04-14
HK1061861A1 (en) 2004-10-08
BRPI0111731C1 (pt) 2021-07-27
PL213363B1 (pl) 2013-02-28
US6632601B2 (en) 2003-10-14
HUP0500444A2 (hu) 2005-08-29
CN100463922C (zh) 2009-02-25
DK1354204T3 (da) 2007-04-10
AU2001272945A1 (en) 2001-12-24
CN1660913A (zh) 2005-08-31
US6797809B2 (en) 2004-09-28

Similar Documents

Publication Publication Date Title
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
AR006016A1 (es) Metodo para determinar h.pylori en muestras fecales y un equipo (kit) para realizar dicho metodo
WO2002090961A3 (en) Systems and methods for detection of analytes in biological fluids
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
BR0314166A (pt) Teste de hcv
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
DE10190630D2 (de) Verfahren zum Nachweis von Helicobacter Pylori und Heilmanii in Stuhl- und Speichelproben und Biopsiematerial
MY137138A (en) Diagnostic reagents and preparing methods thereof
DE69830174D1 (de) Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene
MXPA04003980A (es) Prueba serologica rapida para paratuberculosis utilizando tecnologia de polarizacion por fluorescencia.
UY26379A1 (es) Ensayo inmunoenzimático ligado a enzimas de inhibición (ielisa) para la detección y cuantificación de anticuerpos en muestras biológicas
AR037215A1 (es) Reactivos para la deteccion simultanea de anticuerpos y antigenos nucleares del hcv